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The potential of the common biosynthetic precursor of neurophysin and neuropeptide hormones to self- 
associate has been assessed by quantitative affinity chromatographic analysis. The precursor form, with 
the hormone sequence in the amino terminal region and assumed able to interact intramolecularly with 
the hormone binding site of the neurophysin domain of the folded precursor, exhibits an affinity for 
neurophysin-agarose which is intermediate between those of unliganded neurophysin and non-covalently 
hormone-liganded neurophysin. The results lead to a prediction that neurophysin self-association is 
established upon precursor synthesis and prior to limited proteolysis of the precursor to release mature 
neurophysin and hormone components. Such self-association could play a role in packaging of the 
precursor into secretory granules and in regulating subsequent precursor processing events within the 
granules. 
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1. INTRODUCTION 
Neurophysins and the neuropeptide hormones, 
oxytocin and vasopressin, interact with 
neurosecretory granules to form non-covalent 
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Abbreviations: BNP-II, bovine neurophysin II 
(vasopressin-associated); NP, neurophysin; LVP and 
AVP, lysine and arginine vasopressin; OT, oxytocin; 
pro-NP/AVP, pulse-labelled biosynthetic precursor for 
AVP and AVP-associated NP; pro-NP/OT, pulse- 
labelled biosynthetic precursor for OT and OT- 
associated NP; Kt NP, dissociation constant of unligand- 
ed, soluble NP for unliganded, immobilized NP; KTpL 
dissociation constant of liganded, soluble NP for ligand- 
ed, immobilized NP; KpNP, dissociation constant of 
rat pro-NP/harmone for unliganded, immobilized NP 
complexes, with the latter serving for storage of 
the neuropolypeptides in the posterior pituitary 
after axonal transport from the hypothalamus 
[1,2]. In the granules of a particular peptide 
secretory neuron, only one of the two major NP’s 
is present and is associated with only one of the 
two hormones. This is a consequence of biosyn- 
thesis of the protein-peptide molecular pairs in 
single-chain common precursors [3,4] and the pro- 
duction of only one such precursor type by a par- 
ticular neuron. In vitro, the neurophysin-neuro- 
peptide hormone system is characterized by a func- 
tional interdependence of non-covalent hormone 
binding and NP self-association [2,5]. Thus, NP 
self-association, which can occur in the absence of 
peptide hormone, is enhanced by binding of hor- 
mone or hormone analogue. The resultant mutual 
enhancement of self-association and hormone 
binding may be an important element in the 
neurosecretory storage of the protein-neuropep- 
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tide complexes, for example to help concentrate 
precursor in the secretory granule forming in the 
Golgi, to regulate precursor processing within the 
granule or to regulate intragranular osmotic 
pressure [6]. 
It was proposed previously that the hormone 
binding surface on the neurophysin molecule is 
established upon folding of the neurophysin- 
hormone common precursor [2,7]. This is sug- 
gested not only by the fact that the hormone se- 
quence is contained in the NP precursor [3,4] but 
also by the observation that NP disulfide forma- 
tion, and therefore NP folding as a whole, must 
occur before proteolytic processing of the precur- 
sor [8,9]. It is thus reasonable to propose that the 
self-association surface on NP is also formed upon 
precursor folding. If this surface is accessible, 
folded precursor molecules would self-associate, 
with an affinity modulated by the intramolecular 
interaction between NP and peptide hormone 
domains. 
In order to examine the self-association poten- 
tial of NP precursors, we used quantitative affinity 
chromatography [lO,ll]. In [12-141, we found 
that the presence of a functioning self-association 
surface in NP’s and NP derivatives could be 
measured with NP-Sepharose, by following either 
the degree of retardation of radiolabelled NP on 
this matrix or the extent of interference with this 
retardation by added unlabelled protein. The 
method is appropriate for analysis of the micro 
amounts of available NP-hormone precursors. 
2. MATERIALS AND METHODS 
BNP-II was isolated and fractionated as in 
[ 12,131, with all of the protein samples purified by 
affinity chromatography before use. [‘251]BNP-II 
was prepared as in [12]. LVP was from 
Calbiochem. Rat pro-NP/AVP and pro-NP/OT 
were obtained as either [3H]Cys- or [3’S]Cys- 
containing species by pulse labelling as in [ 151, 
with fractionation by gel filtration and im- 
munoprecipitation before use. 
[BNP-II]-Sepharose preparation and affinity 
chromatographic procedures were similar to those 
in [12,13]. For elutions with [‘251]BNP-II, about 
1 pg amounts of protein were applied to the affini- 
ty column. For elutions of [3H]pro-NP/AVP and 
-NP/OT and [35S]pro-NP/AVP, very small 
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amounts (less than 10 ng) were applied to the af- 
finity column. 
Other details of materials and methods are cited 
in the text. 
3. RESULTS AND DISCUSSION 
The data of fig.1 show the behaviour of both 
unliganded and liganded neurophysin on [BNP- 
II]-Sepharose. As expected from [ 12,131, 
[‘251]BNP-II is retarded significantly when eluted 
in buffer without added hormone (see fig.1 inset 
for unliganded NP). The elution volume, V = 
5.3 + 0.1 ml, reflects a dissociation constant 
(KF’) of unliganded BNP-II for unliganded im- 
mobilized BNP-II of 1.4 x 10e5 f 0.1 x 10m5 M, 
[“*II BNP II Elution on IBNP Ill-Sspharose 
I+--*-’ ’ ’ ’ ’ ’ ’ ’ ’ 100 150 
ml Elutm 
Fig. 1. Elution of [1251]BNP-II on [BNP-II]-Sepharose 
(1.5 ml bed volume, prepared as in [17,2.5]) in the 
presence and absence of neuropeptide ligand. Main 
figure: elution of - 1 pg [1251]BNP-II (containing 
- 16000 cpm, iodinated by amino group modification as 
in [12]) in the presence of 0.1 mM lysine vasopressin 
(LVP, Sigma), in 0.4 M ammonium acetate (pH 5.7) 
containing 1% bovine serum albumin (BSA fraction V, 
Pentex). Eluted radiolabel was followed with a Beckman 
Gamma 4000 counter. Inset: elution of -1 pg [r2’I]BNP- 
II in 0.4 M ammonium acetate (pH 5.7) containing 1% 
BSA. Radiolabelled protein was applied to the affinity 
column in 0.3 ml in both cases. Values of elution 
volumes (v) were determined by triangulation of the 
elution profiles. 
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as calculated from the expression [lo, 1 I]: 
KE = (V, - Vm) [L]/( I/- VO) (1) 
where: V,, (unretarded elution volume, measured 
with [3H]RNase-A) = 1.3 ml; V,,, (excluded 
volume, measured with dextran blue) = 0.5 ml; 
and [L] (immobilized protein concentration, 
measured by amino acid analysis) = 0.07 pmol/ml 
bed volume. Eq.1 is based on a model of 1: 1 in- 
teractions of soluble and immobilized molecules. 
In the case of unliganded NP elution in fig. 1, eq. 1 
holds since the concentration of soluble NP is suf- 
ficiently small that self-association of soluble NP 
monomers can be ignored. 
In the presence of 0.1 mM LVP in the elution 
buffer, BNP-II retardation is much stronger, with 
V = 130 f 5 ml (fig. 1). From eq. 1, apparent KFpL 
= 4.4 x IO-’ rt 0.2 x lo-’ M. Since the immobiliz- 
ed BNP-II is also capable of binding peptide 
ligands [16], the data of fig. i indicate that liganded 
NP self-association is at least 30-times stronger 
than that of unliganded NP. That the differential 
is greater is considered likely on two bases: (i) The 
LVP concentration in the eluting buffer in fig.1 
(1 x 10e4 M) approaches but does not achieve full 
saturation of NP (& for BNP-II is 6.6 X 10e5 M 
at pH 5.7 for LVP under the chromatographic 
conditions [12]); (ii) The concentration of soluble 
NP in the initial zone of applied protein is in a 
range (10-6-10-7 M) at which significant self- 
association of soluble, liganded monomer can oc- 
cur. While dilution will ensue during elution, par- 
tial self-association in the initial zone would 
decrease the magnitude of observed retardation of 
soluble protein and thus would also reduce the 
observed increase in affinity of liganded vs 
unliganded protein for immobilized NP. Based on 
the above, the apparent value of KFL must be 
considered an upper limit. 
When rat t3H]pro-NP/AVP is eluted on [BNP- 
II]-Sepharose, the elution profile shown in fig.2 is 
obtained. Here, retardation of the major portion 
of the rat pro-NP/AVP preparation, I/ = 21.5 f 
1.5 ml, is greater than that for [1251]BNP-II alone 
(fig. 1). The unretarded peak in fig.2 is assumed to 
be non-specific or inactive protein present in the 
pro-NP/AVP preparation. From the elution 
volume of the retarded pro-NP/AVP and eq.1, 
KFNP = 2.8 x 10e6 f 0.2 x 10e6 M, compared 
to KFpL = 1.4 x 10m5 ? 0.1 x 10m5 M and 
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Fig.2. Elution of rat [3H]pro-NP/AVP on [BNP- 
II]-Sepharose (column as in fig.1 legend) with 0.4 M 
ammonium acetate buffer (pH 5.7) containing 1% BSA. 
The precursor protein was prepared as a [3H]Cys- 
containing species, by pulse labelling and subsequent 
isolation by gel filtration and immunoprecipitation [15]. 
It was applied to the affinity column in a zone of 0.44 ml 
of 0.4 M ammonium acetate (pH 5.7) containing either 
1.1 mg (by wt) BSA (o--o) or 1.1 mg (by wt) of an 
approximately equimolar mixture of BNP-I and -II 
(O---O). Elution of radiolabelled protein was followed 
by scintillation counting with a Nuclear Chicago Mark 
III Counter. The elution volume (v) was determined by 
triangulation of the elution profile. 
apparent KFpL = 4.4 x lo-’ f 0.2 x lo-’ M. 
That the retardation of pro-NP/AVP is specific is 
indicated, also in fig.2, by the observation that ad- 
dition of a relatively large amount of bovine 
neurophysin (a mixture of BNP-I and -11) to the 
zone of [3H]pro-NP/AVP before applying to 
[BNP-II]-Sepharose leads to elution of all labelled 
protein without retardation. 
In other precursor experiments not shown in 
fig.2, the elution profile of rat [3H]pro-NP/OT 
also showed significant (greater than unliganded 
BNP-II) retardation of most of this precursor 
preparation on [BNP-II]-Sepharose. In addition, 
elution of [35S]pro-NP/AVP gave results essential- 
ly as shown in fig.2. Interestingly, a previous study 
[15] also showed retardation of pro-NP/hormone 
species on immobilized NP, although in that case, 
elution of precursors was not observed upon pro- 
longed elution with 0.1 M ammonium acetate (pH 
5.7) and could be accomplished only with a Triton- 
formic acid mixture. 
363 
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Fig.3. Schematic diagram depicting the onset of NP self-association upon biosynthesis of pro-NP/hormone precursors 
and their packaging into neurosecretory granules. Subsequent proteolytic processing within the granules i viewed as 
leading to mature NP-hormone non-covalent complexes which can also self-associate to an extent which is enhanced 
by hormone binding. (Figure adapted from [17].) 
The results of fig.2 argue that pro-NP/AVP not 
only can associate with mature NP but that this 
association is stronger than that expected for 
mature, unliganded NP with itself (fig.1). Given 
the stronger association of liganded vs unliganded 
NP as seen quantitatively in fig. 1, it would appear 
that pro-NP/hormone precursor behaves in pro- 
tein association more like the liganded (active site 
occupied) form. Since the present data describe on- 
ly pro-NP/hormone association with unliganded 
NP as the immobilized species, it is reasonable to 
propose that pro-NP/hormone self-association 
likely is stronger, approaching perhaps more close- 
ly the degree of self-association affinity of ligand- 
ed NP reflected in fig. 1. 
In view of the present data, a simplified model 
for the onset of NP self-association is proposed as 
shown in fig.3. According to this model, the NP- 
hormone common precursor self-associates upon 
precursor folding and before proteolytic process- 
ing to non-covalent NP-hormone complexes. The 
surface for ultimate intermolecular neurophy- 
sin-hormone contact is also shown to form first in 
the folded precursor, as an intramolecular contact 
between two domains [7]. In this regard, the for- 
mation of protein-peptide hormone non-covalent 
complexes from folded precursors is analogous to 
the case for bovine pancreatic ribonuclease A; in 
the latter [ 181, S-peptide and S-protein ‘domains’ 
in ribonuclease A form an intramolecular contact 
which is retained as an intermolecular contact 
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upon limited proteolysis to ribonuclease S. The 
observation of NP/hormone precursor self-asso- 
ciation lends credence to the possibility that pro- 
tein self-association is a driving force in the con- 
densation and packaging of precursor molecules 
into secretory granules and has an effect on subse- 
quent intragranular processing [2,19]. 
REFERENCES 
111 
PI 
[31 
141 
151 
161 
[71 
VI 
191 
1101 
1111 
WI 
Pickering, B.T. (1978) Essays in Biochemistry 14, 
45-81. 
Chaiken, I.M., Abercrombie, D.M., Kanmera, T. 
and Sequeira, R.P. (1983) in: Pept. Prot. Rev. 
vol.1 (Hearn, M.T.W. ed) pp.139-207, Marcel 
Dekker, New York. 
Brownstein, M.J., Russell, J.T. and Gainer, H. 
(1980) Science 207, 373-378. 
Ivell, R., Schmale, H. and Richter, D. (1983) 
Neuroendocrinology 37, 235-240. 
Cohen, P., Nicolas, P. and Carmier, M. (1979) 
Topics in Cellular Regulation 15, 263-318. 
Palade, G. (1975) Science 189, 347-358. 
Chaiken, I.M. (1983) Biopolymers 22, 355-362. 
Chaiken, I.M., Randolph, R.E. and Taylor, H.C. 
(1975) Ann. NY Acad. Sci. 248, 442-450. 
Menendez-Botet, C.J. and Breslow, E. (1975) 
Biochemistry 14, 3825-3835. 
Dunn, B.M. and Chaiken, I.M. (1974) Proc. Natl. 
Acad. Sci. USA 71, 2382-2385. 
Chaiken, I.M. (1979) Anal. Biochem. 97, l-10. 
Angal, S. and Chaiken, I.M. (1982) Biochemistry 
21, 1574-1580. 
Volume 164, number 2 FEBS LETTERS December 1983 
[13] Abercrombie, D.M., Angal, S., Sequeira, R.P. and 
Chaiken, I.M. (1982) Biochemistry 21, 6458-6465. 
[14] Abercrombie, D.M., Tamaoki, H. and Chaiken, 
I.M. (1983) in: Affinity Chromatography and 
Biological Recognition (Chaiken, I.M. et al. eds) 
Academic Press, New York, in press. 
[15] Russell, J.T., Brownstein, M.J. and Gainer, H. 
(1980) Endocrinology 107, 1880-1890. 
[16] Kanmera, T., Feinstein, G. and Chaiken, I.M. 
(1983) Proc. 8th Amer. Pept. Symp. (Hruby, V. ed) 
Pierce Chem. Co., Rockford, IL, in press. 
[17] Chaiken, I.M., Hough, C.J., Feinstein, G., Angal, 
S. and Abercrombie, D.M. (1981) in: Peptides - 
Structures, Synthesis, Function (Rich, D.H. and 
Gross, E. eds) pp.501-504, Pierce Chem. Co., 
Rockford, IL. 
[18] Richards, F.M. and Vithayathil, P.J. (1959) J. 
Biol. Chem. 234, 1459-1465. 
[19] Gainer, H. (1982) in: Mol. Gen. Neuroscience 
(Schmitt, F.O. et al. eds) pp.171-187, Raven, New 
York. 
365 
